Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-017473
Filing Date
2025-10-08
Accepted
2025-10-08 17:35:00
Documents
1
Period of Report
2025-10-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4530
  Complete submission text file 0001493152-25-017473.txt   6166
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Issuer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O INTRINSIC MEDICINE, INC. 500 YALE AVENUE NORTH SEATTLE WA 98109
Business Address
Chuang Emil (Reporting) CIK: 0001921045 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33672 | Film No.: 251383236